Product Program year 2020 Source: CMS Open Payments

FreeStyle Libre

Device Diabetes Care

Open in the dashboard

General payments

$599,030

14,186 payments

Research payments

$1,729,585

306 payments

Through program year 2020, $599,030 in general payments and $1,729,585 in research payments were reported against FreeStyle Libre (Diabetes Care).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $166,681 6,421
2020 Research $1,595,111 237
2019 General $432,349 7,765
2019 Research $134,475 69

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $599,030 14,186 payments
Top recipients General payments · program year 2020
  1. Grace Carlson Internal Medicine · Berkeley, CA $16,824 10% · 11 payments
  2. David Maahs Pediatric Endocrinology · Stanford, CA $9,363 6% · 4 payments
  3. Richard Bergenstal Endocrinology, Diabetes & Metabolism · St Louis Park, MN $8,937 5% · 4 payments
  4. Eugene Wright Internal Medicine · Fayetteville, NC $7,946 5% · 6 payments
  5. Rayhan Lal Endocrinology, Diabetes & Metabolism · Stanford, CA $4,263 3% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Endocrinology, Diabetes & Metabolism Internal Medicine $79,179 50% · 1,270 practitioners
  2. Internal Medicine $44,150 28% · 692 practitioners
  3. Family Medicine $19,859 12% · 654 practitioners
  4. Pediatric Endocrinology Pediatrics $10,840 7% · 57 practitioners
  5. Geriatric Medicine Internal Medicine $495 <1% · 16 practitioners

The top 5 of 63 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. California $42,911 26% · 257 recipients
  2. Texas $13,033 8% · 327 recipients
  3. Florida $10,281 6% · 255 recipients
  4. North Carolina $10,162 6% · 42 recipients
  5. Minnesota $9,181 6% · 5 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

14,186 general · 306 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record